SHL 0.78% $29.14 sonic healthcare limited

sie generic pharmaceuticals

  1. 5,447 Posts.
    SciGen,the Sonic Health spin off is targeting the generic pharmaceutical market.This is the expiring patents on various drugs,vaccines around the world enabling generic products to be manufactured without patent constraints.Products that will have patent expiry by 2005 have worldwide sales of US$100 billion.A fraction of this is worth building a business around.They already have some products on the market and many more in the pipeline awaiting expiry dates.Foreign shareholders who could not participate in the spin off are selling at the moment,which has given an opportunity to local investors to buy at bargain prices.Sonic has retained its current holding,actually increasing to 74% while selling to outside investors.This shows confidence in the business.Very similar to CSL float and Cochlear spin off.Worth watching.
 
watchlist Created with Sketch. Add SHL (ASX) to my watchlist
(20min delay)
Last
$29.14
Change
-0.230(0.78%)
Mkt cap ! $13.83B
Open High Low Value Volume
$29.30 $29.48 $29.06 $44.92M 1.542M

Buyers (Bids)

No. Vol. Price($)
2 9940 $29.13
 

Sellers (Offers)

Price($) Vol. No.
$29.15 5889 3
View Market Depth
Last trade - 16.10pm 18/11/2019 (20 minute delay) ?
(live)
Last
$29.08
  Change
-0.230 ( 0.88 %)
Open High Low Volume
$29.31 $29.48 $29.06 54136
Last updated 15.59pm 18/11/2019 (live) ?
SHL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.